No effect of glutamate on metabolic disturbances in hippocampal slices of mature fetal guinea pigs after transient in vitro ischemia

Developmental Brain Research

Volumn 101, Issue 1-2, 1997, Pages 49-56

  Berger, Richard ^a,b,c   Jensen, Arne ^b   Hossmann, Konstantin Alexander ^a   Paschen, Wulf ^a  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Energy metabolism; Glutamate; Guinea pig; Hippocampal slice; Ischemia; Ontogeny; Protein synthesis

Indexed keywords

GLUTAMIC ACID;

ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN METABOLISM; GUINEA PIG; HIPPOCAMPUS; NONHUMAN; ONTOGENY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ADENOSINE TRIPHOSPHATE; ANIMALS; DIZOCILPINE MALEATE; ENERGY METABOLISM; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLUTAMIC ACID; GUINEA PIGS; HIPPOCAMPUS; ISCHEMIC ATTACK, TRANSIENT; KINETICS; KYNURENIC ACID; NERVE TISSUE PROTEINS; PREGNANCY;

ANIMALIA; CAVIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0030879896     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(97)00047-3     Document Type: Article

References (61)

1. Aitken P.G., Balestrino M., Somjen G.G. NMDA antagonists: lack of protective effect against hypoxic damage in CA1 region of hippocampal slices. Neurosci. Lett. 89:1988;187-192.
2. Albers G.W., Goldberg M.P., Choi D.W. Do NMDA antagonists prevent neuronal injury? Yes. Arch. Neurol. 49:1992;418-420.
3. Andiné P., Lehmann A., Ellrén K., Wennberg E., Kjellmer I., Nielsen T., Hagberg H. The excitatory amino acid antagonist kynurenic acid administered after hypoxic ischemia in neonatal rat offers neuroprotection. Neurosci. Lett. 90:1988;208-212.
4. Atkinson D.E. The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry. 7:1968;4030-4034.
5. Beneveniste H., Drejer J., Schousboe A., Diemer N.M. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
6. Berger R., Djuricic B., Jensen A., Hossmann K.-A., Paschen W. Ontogenetic differences in energy metabolism and inhibition of protein synthesis in hippocampal slices during ischemia and 24 h of recovery. Dev. Brain Res. 91:1996;281-291.
7. Bernstein J., Fisher R.S. Excessive glutamate as an inhibitor of excitatory transmission in rat hippocampal slice. Neurosci. Lett. 61:1985;19-24.
8. Bradford H.F., Young A.M.J., Crowder J.M. Continuous leakage from brain cells is balanced by compensatory high-affinity reuptake transport. Neurosci. Lett. 81:1987;296-302.
9. Bridges R.J., Stanley M.S., Anderson M.W., Cotman C.W., Chamberlin A.R. Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. J. Med. Chem. 34:1991;717-725.
10. Buchan A.M. Do NMDA antagonists prevent neuronal injury? No. Arch. Neurol. 49:1992;420-421.
11. Carter A.J., Mueler R.E. Activation of excitatory amino acid receptors cannot alone account for anoxia-induced impairment of protein synthesis in rat hippocampal slices. J. Neurochem. 57:1991;888-896.
12. Cole A.E., ffrench-Mullen J.M.H., Fisher R.S. Fade of the response to prolonged glutamate application in the rat hippocampal slice. Synapse. 4:1989;11-18.
13. Cotman C.W., Monaghan D.T., Ottersen O.P., Storm-Mathisen J. Anatomical organization of excitatory amino acid receptors and their pathways. Trends Neurosci. 10:1987;273-280.
14. Djuricic B., Röhn G., Paschen W., Hossmann K.-A. Protein synthesis in the hippocampal slice: transient inhibition by glutamate and lasting inhibition by ischemia. Metab. Brain Dis. 9:1994;235-247.
15. Djuricic B., Berger R., Paschen W. Protein synthesis and energy metabolism in hippocampal slices during extended (24 hours) recovery following different periods of ischemia. Metab. Brain Dis. 9:1994;379-391.
16. Dux E., Oschlies U., Wiessner C., Hossmann K.-A. Glutamate-induced ribosomal disaggregation and ultrastructural changes in rat cortical neuronal culture - protective effect of horse serum. Neurosci. Lett. 141:1992;173-176.
17. 19F NMR calcium changes, edema and histology in neonatal rat brain slices during glutamate toxicity. Brain Res. 647:1994;172-176.
18. Espanol M.T., Xu Y., Litt L., Yang G.Y., Chang L.H., James T.L., Weinstein P., Chan P.H. Modulation of glutamate-induced intracellular energy failure in neonatal cerebral cortical slices by kynurenic acid, dizocilpine, and NBQX. J. Cereb. Blood Flow Metab. 14:1994;269-278.
19. Ford L.M., Sanberg P.R., Norman A.B., Fogelson M.H. MK-801 prevents hippocampal neurodegeneration in neonatal hypoxic-ischemic rats. Arch. Neurol. 46:1989;1090-1096.
20. Ganong A.H., Lanthorn T.H., Cotman C.W. Kynurenic acid inhibits synaptic and amino acid-induced responses in the rat hippocampus and spinal cord. Brain Res. 273:1983;170-174.
21. Ganong A.H., Cotman C.W. Kynurenic acid and quinolinic acid act at N-methyl-D-aspartate receptors in the rat hippocampus. J. Pharmacol. Exp. Ther. 236:1986;293-299.
22. Garthwaite G., Williams G.D., Garthwaite J. Glutamate toxicity: an experimental and theoretical analysis. Eur. J. Neurosci. 4:1992;353-360.
23. Giffard R.G., Monyer H., Christine C.W., Choi D.W. Acidosis reduces NMDA receptor activation, glutamate neurotoxicity, and oxygen-glucose deprivation neuronal injury in cortical cultures. Brain Res. 506:1990;339-342.
24. Gilland E., Puka-Sundvall M., Andiné P., Bona E., Hagberg H. Hypoxic-ischemic injury in the neonatal rat brain: effects of pre- and post-treatment with the glutamat release inhibitor BW1003C87. Dev. Brain Res. 83:1994;79-84.
25. Globus M.Y.-T., Busto R., Dietrich W.D., Martinez E., Valdes I., Ginsberg M.D. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis. J. Neurochem. 51:1988;1455-1464.
26. Hagberg H., Andersson P., Kjellmer I., Thiringer K., Thordstein M. Extracellular overflow of glutamate, aspartate, GABA and taurine in the cortex and basal ganglia of fetal lambs during hypoxia-ischemia. Neurosci. Lett. 78:1987;311-317.
27. Hattori H., Morin A.M., Schwartz P.H., Fujikawa D.G., Westerlain C.G. Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat. Neurology. 39:1989;713-718.
28. K.-A. Hossmann, R. Widmann, Ch. Wiessner, E. Dux, B. Djuricic, G. Röhn, Protein synthesis after global ischemia and selective vulnerability, in: J. Krieglstein, H. Oberpichler-Schwenk (Eds.), Pharmacology of Cerebral Ischemia, Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1992, pp. 289-299.
29. K.-A. Hossmann, Mechanisms of ischemic injury: is glutamate involved?, in: J. Krieglstein, H. Oberpichler-Schwenk (Eds.), Pharmacology of Cerebral Ischemia, Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1994, pp. 239-251.
30. Kaku D.A., Giffard R.G., Choi D.W. Neuroprotective effects of glutamate antagonists and extracellular acidity. Science. 260:1993;1516-1518.
31. Kass I.S., Chambers G., Cottrell J.E. The N-methyl-D-aspartate antagonist aminophosphonovaleric acid and MK-801 reduce anoxic damage to dentate granule and CA1 pyramidal cells in the rat hippocampal slice. Exp. Neurol. 103:1989;116-122.
32. Kochhar A., Zivin J.A., Lyden P.D., Mazzarella V. Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia. Arch. Neurol. 45:1988;148-153.
33. Krishtal O.A., Smirnov S.V., Osipchuk Y.V. Changes in the state of the excitatory synaptic system in the hippocampus on prolonged exposure to excitatory amino acids and antagonists. Neurosci. Lett. 85:1988;82-88.
34. Lauritzen M., Hansen A.J. The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression. J. Cereb. Blood Flow Metab. 12:1992;223-229.
35. Lekieffre D., Callebert J., Plotkin M., Boulu R.G. Enhancement of endogenous excitatory amino acids by theophylline does not modify the behavioral and histological consequences of forebraim ischemia. Brain Res. 592:1991;353-357.
36. Lekieffre D., Ghribi O., Callebert J., Allix M., Plotikine M., Boulu R.G. Inhibition of glutamate release in rat hippocampus by kynurenic acid does not protect CA1 cells from forebrain ischemia. Brain Res. 592:1992;333-337.
37. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
38. Martin L.J., Blackstone C.D., Levey A.I., Huganir R.L., Price D.L. AMPA glutamate receptor subunits are differentially distributed in rat brain. Neuroscience. 53:1993;327-358.
39. McDonald J.W., Silverstein F.S., Johnston M.V. MK-801 protects the neonatal brain from hypoxic-ischemic damage. Eur. J. Pharmacol. 140:1987;359-361.
40. Meldrum B. Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. Clin. Sci. 68:1985;113-122.
41. Mitani A., Andou Y., Kataoka K. Selective vulnerabilty of hippocampal CA1 neurons cannot be explained in terms of an increase in glutamate concentration during ischemia in the gerbil brain. Neuroscience. 48:1992;307-313.
42. Nozaki K., Beal M.F. Neuroprotection effects of L-kynurenine on hypoxic-ischemic and NMDA lesions in neonatal rats. J. Cereb. Blood Flow Metab. 12:1992;400-407.
43. Obrenovitch T.P., Richards D.A. Extracellular neurotransmitter changes in cerebral ischemia. Cerebrovasc. Brain Metab. Rev. 7:1995;1-54.
44. Olney J.W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science. 164:1969;719-721.
45. Olney J.W., Sharpe L.G., Feigin R.D. Glutamate-induced brain damage in infant primates. J. Neuropathol. Exp. Neurol. 31:1972;464-488.
46. Olney J.W., Ikonomidou J.L., Mosinger J.L., Friedrich G. MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain. J. Neurosci. 9:1989;1701-1704.
47. Orrego F., Lipmann F. Protein synthesis in brain slices. J. Biol. Chem. 242:1967;665-671.
48. Park C.K., Nehls D.G., Teasdale G.M., McCulloch J. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann. Neurol. 24:1988;543-551.
49. Paschen W. Glutamate excitotoxicity in transient global cerebral ischemia. Acta Neurobiol. Exp. (Warsz.). 56:1996;313-322.
50. Penning D.H., Patrick J., Jimmo S., Brien J.F. Release of glutamate and gamma-aminobutyric acid in the ovine fetal hippocampus: ontogeny and effect of hypoxia. J. Dev. Physiol. 16:1991;301-307.
51. Penning D.H., Chestnut D.H., Dexter F., Hrdy J., Poduska D., Atkin B. Glutamate release from the ovine fetal brain during maternal hemorrhage. Anesthesiology. 82:1995;521-530.
52. Raley-Susman K.M., Lipton P. In vitro ischemia and protein synthesis in the rat hippocampal slice: the role of calcium and NMDA receptor activation. Brain Res. 515:1990;27-38.
53. Rothman S.M. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J. Neurosci. 4:1984;1884-1891.
54. Rothman S.M., Olney J.W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19:1986;105-111.
55. Tan W.K.M., Williams C.E., Gunn A.J., Mallard C.E., Gluckman P.D. Suppression of postischemic epileptiform activity with MK-801 improves neural outcome in fetal sheep. Ann. Neurol. 32:1992;677-682.
56. Tombaugh G.C., Sapolski R.M. Mechanistic distinction between excitotoxic and acidotic hippocampal damage in an in vitro model of ischemia. J. Cereb. Blood Flow Metab. 10:1990;527-535.
57. Uematsu D., Greenberg J.H., Araki N., Reivich M. Mechanism underlying protective effects of MK-801 against NMDA-induced neuronal injury in vivo. J. Cereb. Blood Flow Metab. 11:1991;779-785.
58. Virgili M., Constestabile A., Barbanei O. Simultaneous blockade of non-NMDA ionotropic receptors and NMDA receptor-associated ionophore partially protects hippocampal slices from protein synthesis impairment due to simulated ischemia. Hippocampus. 5:1995;91-97.
59. Vornov J.J., Coyle J.T. Enhancement of NMDA receptor-mediated neurotoxicity in the hippocampal slice by depolarization and ischemia. Brain Res. 555:1991;99-106.
60. Warner M.A., Neill K.H., Nadler J.V., Crain B.J. Regionally selective effects of NMDA receptor antagonists against ischemic brain damage in the gerbil. J. Cereb. Blood Flow Metab. 11:1991;600-610.
61. Wong E.H.F., Kemp J.A., Priestley T., Knight A.R., Woodruff G.N., Iversen L.L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. (USA). 83:1986;7104-7108.